Publications by authors named "David Fitts"

Claim this Profile
H
Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials.
Thomas P Lodise, Sam Colman, Elizabeth Alexander, Daniel S Stein, David Fitts

Open Forum Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials.
Thomas Lodise, Sam Colman, Daniel S Stein, David Fitts, Lisa Goldberg

Open Forum Infect Dis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial.
Eileen M O'Reilly, Do-Youn Oh, Neesha Dhani, Daniel J Renouf, Myung Ah Lee, David Fitts

JAMA Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks.
William R Lumry, Dave P Miller, Scott Newcomer, David Fitts, Jeffrey Dayno

Allergy Asthma Proc· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
Marc A Riedl, William R Lumry, H Henry Li, Timothy J Craig, David Fitts

Am J Rhinol Allergy· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Stuart Johnson, Thomas J Louie, Dale N Gerding, Oliver A Cornely, Scott Chasan-Taber, David Fitts

Clin Infect Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
Bertil Ekman, David Fitts, Claudio Marelli, Robert D Murray, Marcus Quinkler

BMC Endocr Disord· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.
Jonathan A Bernstein, Michael E Manning, Henry Li, Martha V White, James Baker, David Fitts

J Allergy Clin Immunol Pract· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.
James W Baker, Timothy J Craig, Marc A Riedl, Aleena Banerji, David Fitts

Allergy Asthma Proc· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.
William Lumry, Michael E Manning, David S Hurewitz, Mark Davis-Lorton, David Fitts

J Pediatr· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
J Andrew Grant, Martha V White, H Henry Li, David Fitts, Ira N Kalfus

Allergy Asthma Proc· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
Marc A Riedl, David S Hurewitz, Robyn Levy, Paula J Busse, David Fitts

Ann Allergy Asthma Immunol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis